山东鲁抗医药2005年半年度报告（节录）_医药资讯

财务资料1、主要会计数据及财务指标单位:元 币种:人民币主要会计数据本报告期末上年度期末本报告期末比上年度期末增减（％）调整后调整前流动资产905,900,208.4832,264,071.57832,264,071.578.85流动负债1,047,438,136.06972,632,528.2972,632,528.27.69总资产2,726,842,121.882,698,031,691.802,698,031,691.801.07股东权益（不含少数股东权益）1,496,890,011.951,495,371,215.851,495,371,215.850.10每股净资产3.643.633.630.28调整后的每股净资产3.643.633.630.28报告期（1－6月）上年同期本报告期比上年同期增减（％）调整后调整前净利润2,129,549.621,545,870.551,545,870.5537.76扣除非经常性损益后的净利润1,872,748.221,526,604.811,526,604.8122.67每股收益0.00520.00380.003836.84每股收益注10.0052净资产收益率（%）0.1420.1030.103增加0.039个百分点经营活动产生的现金流量净额78,712,021.378,818,516.678,818,516.67792.58 注1：如果报告期末至报告披露日，公司股本发生变化的，按新股本计算。2、扣除非经常性损益项目和金额非经常性损益项目涉及金额（元）（1）营业外收入311,634.35（2）营业外支出54,832.95合计256,801.40扣除所得税影响额后的非经常性损益256,801.403、净资产收益率及每股收益单位:元 币种:人民币报告期利润净资产收益率（%）每股收益全面摊薄加权平均全面摊薄加权平均主营业务利润4.024.020.14610.1461营业利润0.080.080.00310.0031净利润0.140.140.00520.0052扣除非经常性损益后的净利润0.130.130.00450.00454、利润及利润分配表单位:元 币种:人民币项目合并母公司本期数上年同期数本期数上年同期数一、主营业务收入529,891,958.67469,403,427.80518,223,397.50469,403,427.80减：主营业务成本467,734,232.46385,320,377.87456,103,479.95385,320,377.87主营业务税金及附加2,014,008.941,695,051.512,010,024.771,695,051.51二、主营业务利润（亏损以“-”号填列）60,143,717.2782,387,998.4260,109,892.7882,387,998.42加：其他业务利润（亏损以“-”号填列）1,691,854.24984,777.751,691,854.24984,777.75减:营业费用19,851,995.7126,445,086.6119,490,903.7026,445,086.61管理费用25,660,826.3542,443,170.8025,125,495.2342,443,170.80财务费用15,060,754.7512,206,004.1215,060,127.6212,206,004.12三、营业利润（亏损以“-”号填列）1,261,994.702,278,514.642,125,220.472,278,514.64加：投资收益（损失以“-”号填列）补贴收入营业外收入311,634.35343,720.41311,634.35343,720.41减：营业外支出54,832.95314,965.5754,832.95314,965.57四、利润总额（亏损总额以“-”号填列）1,518,796.102,307,269.482,382,021.872,307,269.48减：所得税761,398.93761,398.93减：少数股东损益加：未确认投资损失(合并报表填列)610,753.52五、净利润（亏损以“-”号填列）2,129,549.621,545,870.552,382,021.871,545,870.55加：年初未分配利润102,962,817.18220,015,893.72102,468,605.03220,015,893.72其他转入1,291,702.471,291,702.47六、可供分配的利润105,092,366.80222,853,466.74104,850,626.90222,853,466.74减：提取法定盈余公积提取法定公益金提取职工奖励及福利基金(合并报表填列)提取储备基金提取企业发展基金利润归还投资七、可供股东分配的利润105,092,366.80222,853,466.74104,850,626.90222,853,466.74减：应付优先股股利提取任意盈余公积应付普通股股利24,705,252.9024,705,252.90转作股本的普通股股利八、未分配利润(未弥补亏损以“-”号填列)105,092,366.80198,148,213.84104,850,626.90198,148,213.84 详见《山东鲁抗医药股份有限公司2005年半年度报告》（据“上海证券交易所”；医药网整理，严禁转载） 医药网新闻